Spring Creek Capital’s Biote Corp. Warrant BTMDW Stock Holding History

Spring Creek Capital’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50,000	Closed	-$28K	–	416
2022 Q1	$28K	Hold	50,000	–	–	﹤0.01%	659
2021 Q4	$36K	Hold	50,000	–	–	﹤0.01%	593
2021 Q3	$41K	Hold	50,000	–	–	﹤0.01%	499
2021 Q2	$53K	Buy	+50,000	New	+$43.2K	﹤0.01%	492

Other funds holding BTMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Spring Creek Capital's BTMDW Position: Q2 2022 in Review

Spring Creek Capital sold out of Biote Corp. Warrant (BTMDW) in Q2 2022, closing a stake of 50,000 shares — an estimated $28K sold.

Spring Creek Capital first reported a position in BTMDW in Q2 2021 and held it in 4 quarters. The position peaked at $53K in Q2 2021. 42 funds tracked by Wall St. Rank hold BTMDW as of Q2 2022.

Spring Creek Capital reported no remaining Biote Corp. Warrant position as of Q2 2022 after selling out during the quarter.
Spring Creek Capital sold 50,000 Biote Corp. Warrant shares in Q2 2022, an estimated $28K.
Spring Creek Capital first reported a position in Biote Corp. Warrant in Q2 2021 and held it in 4 quarters.
Spring Creek Capital's Biote Corp. Warrant position peaked at $53K in Q2 2021.
42 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q2 2022.

Based on Spring Creek Capital's 13F filing for Q2 2022.